XML 37 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Summary of Loss Before Income Taxes

Loss before income taxes are as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Losses before income taxes:

 

 

 

 

 

 

U.S.

 

$

(88,159

)

 

$

(37,055

)

Non-U.S.

 

 

193

 

 

 

195

 

Total

 

$

(87,966

)

 

$

(36,860

)

Summary of Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes are as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

(2,746

)

State

 

 

 

 

 

392

 

Foreign

 

 

 

 

 

 

 

 

 

 

 

 

(2,354

)

Provision (benefit) for income taxes

 

$

 

 

$

(2,354

)

Reconciliation of U.S. Federal Statutory Income Tax Rate

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Statutory Federal income tax rate

 

$

(18,473

)

 

$

(7,741

)

State income taxes, net of Federal tax benefits

 

 

(2,678

)

 

 

(445

)

Tax credits

 

 

(1,046

)

 

 

(651

)

Stock-based compensation

 

 

986

 

 

 

651

 

Permanent items

 

 

3

 

 

 

2

 

State rate differential

 

 

274

 

 

 

235

 

NOL true-up

 

 

(337

)

 

 

(991

)

Other

 

 

114

 

 

 

146

 

Goodwill impairment

 

 

11,697

 

 

 

 

Change in valuation allowance

 

 

9,460

 

 

 

6,440

 

Total provision (benefit) for income taxes

 

$

 

 

$

(2,354

)

Schedule of Significant Components Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2022 and 2021 consisted of the following (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Net operating loss carryforwards

 

$

15,230

 

 

$

12,531

 

Research and development tax credits

 

 

2,294

 

 

 

1,356

 

Accruals and reserves

 

 

452

 

 

 

296

 

Research expenditures

 

 

5,264

 

 

 

 

Stock-based compensation

 

 

2,874

 

 

 

1,867

 

Depreciation and amortization

 

 

1,595

 

 

 

1,713

 

Lease liability

 

 

179

 

 

 

171

 

Total deferred tax assets

 

 

27,888

 

 

 

17,934

 

Right-of-use asset

 

 

(178

)

 

 

(171

)

Acquired IPR&D

 

 

(7,787

)

 

 

(7,192

)

Total deferred tax liabilities

 

 

(7,965

)

 

 

(7,363

)

Less: valuation allowance

 

 

(21,675

)

 

 

(12,323

)

Net deferred tax liabilities

 

$

(1,752

)

 

$

(1,752

)

Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits

The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Gross unrecognized tax benefits at the beginning of the year

 

$

1,469

 

 

$

764

 

Additions from tax positions taken in the current year

 

 

914

 

 

 

712

 

Additions from tax positions taken in prior years

 

 

281

 

 

 

 

Reductions from tax positions taken in prior years

 

 

 

 

 

(7

)

Gross unrecognized tax benefits at the end of the year

 

$

2,664

 

 

$

1,469